Osteopenia: A Diagnostic and Therapeutic Challenge

We discussed whether we are able to select a subgroup of patients with osteopenia having a high fracture risk, in which anti-osteoporotic drug treatment can be advocated. We concluded that in individuals in whom, based on clinical risk factors, a dual-energy x-ray absorptiometry (DXA) was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lems, Willem F., Raterman, Hennie G., van den Bergh, Joop P. W., Bijlsma, Hans W. J., Valk, Niek K., Zillikens, M. Carola, Geusens, Piet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149119/
https://www.ncbi.nlm.nih.gov/pubmed/21695407
http://dx.doi.org/10.1007/s11914-011-0062-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149119/
https://www.ncbi.nlm.nih.gov/pubmed/21695407
http://dx.doi.org/10.1007/s11914-011-0062-3

Ejemplares similares